About Scar Treatment
Scars are treated using both invasive techniques such as surgery and non-invasive techniques such as OTC treatment products. These products and procedures are used to treat all types of scars, such as keloid scars, contracture scars, hypertrophic scars, and atrophic scars. Scars caused by surgery can be removed by surgical revisions, although most people are reluctant to go for another invasive procedure after a surgery. Apart from the easily available OTC scar treatment products, patients can also opt for less-known alternatives such as cryotherapy, clinical peel, and compression.
TechNavio's analysts forecast the Global Scar Treatment market to grow at a CAGR of 9.09 percent over the period 2014-2019.
Covered in this Report
The Global Scar Treatment market can be divided into the following segments based on application: Burn Scars, Post-Surgical Scars, Other than Burn Scars, and Others.
TechNavio's report, Global Scar Treatment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the US, Europe, and the ROW; it also covers the Global Scar Treatment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Europe
• ROW
• US
Key Vendors
• Avita Medical
• CCA Industries
• Enaltus
• Merz Pharmaceuticals
• Oculus Innovative Sciences
• Pacific World
• Revitol
• Scarguard Labs
• Suneva Medical
• Valeant Pharmaceuticals International
Other Prominent Vendors
• Absolute MS
• Allergan
• Avocet Polymer Technologies
• Biodermis
• Menarini Asia-Pacific
• NewMedical Technology
• Senvie
• SKINCEPTION
Key Market Driver
• Increased Emphasis on Beauty
• For a full, detailed list, view our report
Key Market Challenge
• Risks Associated with Scar Treatment Products
• For a full, detailed list, view our report
Key Market Trend
• Increased Use of Silicone-based Products
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
07. Global Scar Treatment Market
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Application
08.1 Segmentation of Global Scar Treatment Market by Application
08.1.1 Burn Scars
08.1.2 Post-surgical Scars Other than Burn Scars
08.1.3 Others
09. Market Segmentation by Type of Treatment
09.1 Segmentation of Global Scar Treatment Market by Type of Treatment
09.2 OTC Scar Treatment Products
09.3 Alternative Treatment Methods
09.3.1 Dressings and Compression Treatment
09.3.2 Massage Treatment
09.3.3 Laser Treatment and Radiotherapy
09.3.4 Corticosteroid Treatment
09.3.5 Cryotherapy
09.3.6 Surgical Revision
10. Geographical Segmentation
10.1 Segmentation of Global Scar Treatment Market by Geography 2014-2019
10.2 Scar Treatment Market in Europe
10.2.1 Market Size and Forecast
10.3 Scar Treatment Market in US
10.3.1 Market Size and Forecast
10.4 Scar Treatment Market in ROW
10.4.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.2 Major Vendors 2014
18.2.1 Key News
18.3 Other Prominent Vendors
18.4 Product Portfolio: Other Prominent Vendors
19. Key Vendor Analysis
19.1 Avita Medical
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2014
19.1.4 Business Segmentation by Revenue 2013 and 2014
19.1.5 Geographical Segmentation by Revenue 2014
19.1.6 Business Strategy
19.1.7 Recent Developments
19.1.8 SWOT Analysis
19.2 CCA Industries
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Product Segmentation by Revenue 2013
19.2.4 Product Segmentation by Revenue 2012 and 2013
19.2.5 Geographical Segmentation by Revenue 2013
19.2.6 Business Strategy
19.2.7 Recent Developments
19.2.8 SWOT Analysis
19.3 Enaltus
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 SWOT Analysis
19.4 Merz Pharma
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Subsidiaries
19.4.4 Key Products
19.4.5 Therapeutic Areas
19.4.6 Geographical Presence
19.4.7 Business Strategy
19.4.8 Recent Developments
19.4.9 SWOT Analysis
19.5 Oculus Innovative Sciences
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Segmentation by Revenue 2014
19.5.4 Segmentation by Revenue 2013 and 2014
19.5.5 Geographical Segmentation by Product Revenue 2014
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 Pacific World
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Recent Developments
19.6.4 SWOT Analysis
19.7 Revitol
19.7.1 Key Facts
19.7.2 Business Overview
19.7.3 Product Segmentation
19.7.4 SWOT Analysis
19.8 Scarguard Labs
19.8.1 Key Facts
19.8.2 Business Overview
19.8.3 Key Products
19.8.4 SWOT Analysis
19.9 Suneva Medical
19.9.1 Key Facts
19.9.2 Business Overview
19.9.3 Key Offerings
19.9.4 Business Strategy
19.9.5 Recent Developments
19.9.6 SWOT Analysis
19.10 Valeant Pharmaceuticals International
19.10.1 Key Facts
19.10.2 Business Overview
19.10.3 Business Segmentation by Revenue 2013
19.10.4 Business Segmentation by Revenue 2012 and 2013
19.10.5 Sales by Geography
19.10.6 Business Strategy
19.10.7 Key Developments
19.10.8 SWOT Analysis
20. Other Reports in this Series
?
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Segmentation of Global Scar Treatment Market
Exhibit 3: Segmentation of Global Scar Treatment Market by Application
Exhibit 4: Segmentation of Global Scar Treatment Market by Type of Treatment
Exhibit 5: Segmentation of Global Scar Treatment Market by Geography
Exhibit 6: Types of Scars
Exhibit 7: Global Scar Treatment Market 2014-2019 (US$ billion)
Exhibit 8: Segmentation of Global Scar Treatment Market by Application 2014
Exhibit 9: Segmentation of Global Scar Treatment Market by Type of Treatment
Exhibit 10: OTC Product-based Treatment
Exhibit 11: Global Scar Treatment Market by Geographical Segmentation 2014 and 2019
Exhibit 12: Segmentation of Global Scar Treatment Market by Geography 2014-2019 (US$ billion)
Exhibit 13: Scar Treatment Market in Europe 2013-2019 (US$ billion)
Exhibit 14: Scar Treatment Market in US 2014-2019 (US$ billion)
Exhibit 15: Scar Treatment Market in ROW 2014-2019 (US$ billion)
Exhibit 16: Major Vendors of Global Scar Treatment Market 2014
Exhibit 17: Product Portfolio: Other Prominent Vendors
Exhibit 18: Avita Medical: Business Segmentation by Revenue 2014
Exhibit 19: Avita Medical: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 20: Avita Medical: Geographical Segmentation by Revenue 2014
Exhibit 21: CCA Industries: Product Segmentation by Revenue 2013
Exhibit 22: CCA Industries: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 23: CCA Industries: Geographical Segmentation by Revenue 2013
Exhibit 24: Merz Pharma: Subsidiaries
Exhibit 25: Merz Pharma: Key Products
Exhibit 26: Merz Pharma: Therapeutic Areas
Exhibit 27: Merz Pharma: Geographical Presence
Exhibit 28: Oculus Innovative Sciences: Segmentation by Revenue 2014
Exhibit 29: Oculus Innovative Sciences: Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 30: Oculus Innovative Sciences: Geographical Segmentation by Product Revenue 2014
Exhibit 31: Revitol: Product Segmentation
Exhibit 32: Scarguard Labs: Key Products
Exhibit 33: Suneva Medical: Key Offerings
Exhibit 34: Valeant Pharmaceuticals International: Business Segmentation by Revenue 2013
Exhibit 35: Valeant Pharmaceuticals International: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 36: Valeant Pharmaceuticals International: Sales by Geography 2013
